• LAST PRICE
    2.1000
  • TODAY'S CHANGE (%)
    Trending Down-0.1200 (-5.4054%)
  • Bid / Lots
    2.0800/ 7
  • Ask / Lots
    2.1000/ 6
  • Open / Previous Close
    2.1900 / 2.2200
  • Day Range
    Low 2.0200
    High 2.2042
  • 52 Week Range
    Low 1.1090
    High 4.5600
  • Volume
    221,895
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 2.22
TimeVolumeACER
09:32 ET22672.19
09:33 ET83862.1898
09:35 ET40272.16
09:37 ET14002.15
09:39 ET42502.15
09:42 ET126072.12
09:44 ET59822.14
09:46 ET75102.11
09:48 ET196182.09
09:50 ET105322.097
09:51 ET40002.09
09:53 ET280462.04
09:55 ET137922.05
09:57 ET57032.08
10:00 ET20902.1019
10:02 ET104492.07
10:04 ET16832.0858
10:06 ET40002.0912
10:08 ET2002.09
10:09 ET57292.1202
10:11 ET28812.14
10:18 ET3402.13
10:20 ET4672.131
10:24 ET10002.125
10:27 ET10002.1298
10:29 ET2002.11
10:31 ET1002.12
10:36 ET20002.11
10:40 ET1002.12
10:42 ET4722.1169
10:45 ET11132.12
10:54 ET27132.1
10:56 ET1652.1
11:02 ET3002.105
11:05 ET12322.11
11:14 ET38542.09
11:16 ET12002.08
11:38 ET9042.09
11:41 ET2002.09
11:43 ET2172.1
11:57 ET3462.105
12:03 ET3002.11
12:06 ET10002.1098
12:12 ET2002.13
12:14 ET37002.115
12:15 ET20002.1101
12:44 ET2002.128
12:51 ET1002.1281
12:57 ET15952.12
01:04 ET5002.12
01:06 ET5002.1299
01:09 ET19002.13
01:22 ET1002.135
01:24 ET1002.135
01:29 ET15052.125
01:31 ET2002.11
01:33 ET2002.1151
01:42 ET2002.115
02:03 ET1702.1189
02:07 ET1002.12
02:09 ET1002.13
02:16 ET11002.13
02:18 ET1002.1299
02:20 ET1002.13
02:25 ET6002.12
02:32 ET2032.1175
02:38 ET1502.1135
02:39 ET140812.095
02:41 ET17402.08
02:45 ET5002.09
02:48 ET8102.1
02:50 ET18002.1
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACER
Acer Therapeutics Inc
36.3M
-1.5x
---
United StatesBIOR
Biora Therapeutics Inc
36.2M
-0.2x
---
United StatesPTN
Palatin Technologies Inc
38.7M
-0.9x
---
United StatesEVGN
Evogene Ltd
34.4M
-1.1x
---
United StatesTCON
TRACON Pharmaceuticals Inc
37.5M
-1.1x
---
United StatesALBT
Avalon Globocare Corp
31.9M
-2.5x
---
As of 2023-02-08

Company Information

Acer Therapeutics Inc. is a pharmaceutical company, which is focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. The Company’s pipeline includes four programs: ACER-001 (sodium phenylbutyrate), ACER-801 (osanetant), EDSIVO (celiprolol) and ACER-2820 (emetine). ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); ACER-801 (osanetant) for the treatment of induced vasomotor symptoms (iVMS); EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19.

Contact Information

Headquarters
One Gateway Center (300 Washington St.) Suite 356NEWTON, MA, United States 02458
Phone
---
Fax
302-655-5049

Executives

Independent Chairman of the Board
Stephen Aselage
President, Chief Executive Officer, Director
Chris Schelling
Chief Financial Officer
Harry Palmin
Chief Operating Officer
Tanya Hayden
Chief People Officer
Bernie Paul

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$36.3M
Revenue (TTM)
$360.0K
Shares Outstanding
16.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.62
EPS
$-1.44
Book Value
$-0.12
P/E Ratio
-1.5x
Price/Sales (TTM)
101.0
Price/Cash Flow (TTM)
---
Operating Margin
-6,603.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.